5 insiders reported 14 Form 4 transactions for aTYR PHARMA INC (ATYR) over the past 18 months (most recent 2026-02-04). Recent activity: DENYES NANCY (General Counsel) Sell 1,118 shares, Broadfoot Jill Marie (Chief Financial Officer) Buy 3,750 shares, Broadfoot Jill Marie (Chief Financial Officer) Sell 1,558 shares, Shukla Sanjay (President and CEO) Buy 10,375 shares, Shukla Sanjay (President and CEO) Sell 3,745 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | DENYES NANCY | General Counsel | Sell | 1,118 | $1,096 |
| 2026-02-04 | Broadfoot Jill Marie | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-02-04 | Broadfoot Jill Marie | Chief Financial Officer | Sell | 1,558 | $1,527 |
| 2026-02-04 | Shukla Sanjay | President and CEO | Buy | 10,375 | $0 |
| 2026-02-04 | Shukla Sanjay | President and CEO | Sell | 3,745 | $3,670 |
| 2026-02-04 | DENYES NANCY | General Counsel | Buy | 2,687 | $0 |
| 2025-10-09 | SCHIMMEL PAUL | Director | Buy | 317,999 | $298,919 |
| 2025-10-09 | SCHIMMEL PAUL | Director | Buy | 682,001 | $613,801 |
| 2025-03-17 | Gross Jane A | Director | Buy | 3,750 | $15,000 |
| 2025-02-04 | Shukla Sanjay | President and CEO | Buy | 10,375 | $0 |
| 2025-02-04 | Broadfoot Jill Marie | Chief Financial Officer | Buy | 3,750 | $0 |
| 2025-02-04 | Broadfoot Jill Marie | Chief Financial Officer | Sell | 1,254 | $4,740 |
| 2025-02-04 | DENYES NANCY | General Counsel | Buy | 2,687 | $0 |
| 2025-02-04 | DENYES NANCY | General Counsel | Sell | 899 | $3,398 |
Source: SEC Form 4 filings · as of 2026-02-04
